Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126908031 | 12690803 | 1 | I | 20160715 | 20160826 | 20160826 | PER | US-FRI-1000086226 | FOREST | 0.00 | F | Y | 0.00000 | 20160826 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126908031 | 12690803 | 1 | PS | LEXAPRO | ESCITALOPRAM OXALATE | 1 | 21323 | 20 | MG | ||||||||||
| 126908031 | 12690803 | 2 | SS | LEXAPRO | ESCITALOPRAM OXALATE | 1 | 0 | 10 | MG | ||||||||||
| 126908031 | 12690803 | 3 | SS | LEXAPRO | ESCITALOPRAM OXALATE | 1 | 0 | 15 | MG | ||||||||||
| 126908031 | 12690803 | 4 | SS | REXULTI | BREXPIPRAZOLE | 1 | 0 | .5 | MG | ||||||||||
| 126908031 | 12690803 | 5 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 0 | 60 | MG |
Indications of drugs used
| no results found |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126908031 | 12690803 | Hallucination, visual | |
| 126908031 | 12690803 | Hyperhidrosis | |
| 126908031 | 12690803 | Hypnagogic hallucination | |
| 126908031 | 12690803 | Migraine | |
| 126908031 | 12690803 | Nausea | |
| 126908031 | 12690803 | Vertigo | |
| 126908031 | 12690803 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |